Research output per year
Research output per year
Personal profile
Expertises
Immunotherapy; Oncology; Clinical research
Main research areas
Immunotherapy, Adoptive cell therapy; Ovarian cancer; Renal cell carcinoma
Current research
Immunotherapy, Adoptive cell therapy; Ovarian cancer; Renal cell carcinoma
Fingerprint
Dive into the research topics where Magnus Pedersen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression
Homburg, S., Christensen, C. B., Pedersen, M., Sørensen, S. G., Donia, M., Svane, I. M., Hendel, H. W. & Ellebaek, E., 27 Feb 2024, In: Cancers. 16, 5, 13 p., 964.Research output: Contribution to journal › Journal article › Research › peer-review
-
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
Borch, T. H., Harbst, K., Rana, A. H., Andersen, R., Martinenaite, E., Kongsted, P., Pedersen, M., Nielsen, M., Kjeldsen, J. W., Kverneland, A. H., Lauss, M., Hölmich, L. R., Hendel, H., Met, Ö., Jönsson, G., Donia, M. & Marie Svane, I., Jul 2021, In: Journal for ImmunoTherapy of Cancer. 9, 7, e002703.Research output: Contribution to journal › Journal article › Research › peer-review
15 Citations (Scopus) -
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer
Kverneland, A. H., Pedersen, M., Westergaard, M. C. W., Nielsen, M., Borch, T. H., Olsen, L. R., Aasbjerg, G., Santegoets, S. J., van der Burg, S. H., Milne, K., Nelson, B. H., Met, Ö., Donia, M. & Svane, I. M., 2 Jun 2020, In: Oncotarget. 11, 22, p. 2092-2105 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
77 Citations (Scopus) -
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer
Westergaard, M. C. W., Milne, K., Pedersen, M., Hasselager, T., Olsen, L. R., Anglesio, M. S., Borch, T. H., Kennedy, M., Briggs, G., Ledoux, S., Kreuzinger, C., von der Decken, I., Donia, M., Castillo-Tong, D. C., Nelson, B. H. & Svane, I. M., 18 Dec 2020, In: Cancers. 12, 12, p. 1-19 19 p., 3828.Research output: Contribution to journal › Journal article › Research › peer-review
28 Citations (Scopus) -
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
Friese, C., Harbst, K., Borch, T. H., Westergaard, M. C. W., Pedersen, M., Kverneland, A., Jönsson, G., Donia, M., Svane, I. M. & Met, Ö., 3 Mar 2020, In: Scientific Reports. 10, 1, p. 3914 3914.Research output: Contribution to journal › Journal article › Research › peer-review
52 Citations (Scopus)